End TB
Sí, podemos impedir que las patentes obstaculicen el tratamiento de la tuberculosis
Un día antes del Día Mundial de la Tuberculosis, la Oficina de Patentes de la India rechazó la solicitud del gigante farmacéutico Jannsen de prorrogar la patente del medicamento bedaquilina.
Yes, we can stop patents getting in the way of TB treatment
A day ahead of World TB Day, the Indian Patent Office rejected pharma giant Jannsen’s application for a patent extension on drug bedaquiline. If the patent had been extended, public and family budgets would have remained burdened by unjustifiably high costs of the drug
- Political crisis in Mozambique escalates following controversial election ruling
- Negligent landlords strike again in the Bronx: apartment fire displaces over 200
- Venezuelan President Nicolás Maduro has been sworn in for the 2025-2031 presidential term
- Health workers in Turkey resist profit-driven primary care regulation
- Israel continues to push for “Greater Israel” amid massacres in the West Bank and Gaza
